Neurosense Therapeutics Ltd (NRSN NASDAQ) stock market data APIs
$1.1726
-0.05(-4.3%)
as of September 17, 2025
Try our APIs with
free plan!
Neurosense Therapeutics Ltd Financial Data Overview
Price chart is built with
Anychart
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.
Prev. Close
1.1726
Open
1.1231
High
1.1894
Low
1.1231
52 wk Range
0.8-2.6
Market Cap
29 301 K
Shares Outstanding
25 043 K
EPS
-0.1377
Beta
1.567
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Neurosense Therapeutics Ltd data using free add-ons & libraries
Get Neurosense Therapeutics Ltd Fundamental Data
Neurosense Therapeutics Ltd Fundamental data includes:
- Net Revenue:
- EBITDA: -8 551 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-01
- EPS/Forecast: -0.225
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Neurosense Therapeutics Ltd News
New
Sector Update: Health Care Stocks Retreat Late Afternoon
Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index falling 0.8% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Wednesday's session: top gainers and losers
Wondering how the US markets performed one hour before the close of the markets on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis. [topmovers] GAINERS ...
NeuroSense Therapeutics announces $500,000 private placement
* NeuroSense Therapeutics (NASDAQ:NRSN [https://seekingalpha.com/symbol/NRSN]) announced on Thursday it has entered into a definitive agreement with a single investor for a $500,000 private placemen...
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Here are the top movers in Friday's session, showcasing the stocks with significant price changes. [topmovers] TODAY'S TOP GAINERS TICKER CHANGE COMMENT PHLT [https://www.chartmill.com/s...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
